{
  "guid": "c25093bc-9f01-4f78-ae1e-ac46016dc1bd",
  "title": "433. How Are Psychedelics and Other Party Drugs Changing Psychiatry?",
  "description": "<p>Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.</p>\n",
  "pubDate": "Thu, 1 Oct 2020 03:00:00 +0000",
  "author": "editor@freakonomics.com (Freakonomics Radio + Stitcher)",
  "link": "http://freakonomics.com/",
  "content:encoded": "<p>Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.</p>\n",
  "enclosure": "",
  "itunes:title": "433. How Are Psychedelics and Other Party Drugs Changing Psychiatry?",
  "itunes:author": "Freakonomics Radio + Stitcher",
  "itunes:image": "",
  "itunes:duration": "00:53:34",
  "itunes:summary": "Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.",
  "itunes:subtitle": "Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}